Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î] ±¹¹Î 90% 1³â°£ ÆíÀÇÁ¡ »óºñ¾à ÃÖ´ë 5ȸ ±¸ÀÔ
³»   ¿ë

±¹¹Î 90% 1³â°£ ÆíÀÇÁ¡ »óºñ¾à ÃÖ´ë 5ȸ ±¸ÀÔ

¾ÈÀü»óºñÀǾàǰ ¾à±¹¿Ü ÆÇ¸ÅÁ¦µµ ¿î¿µ ÇöȲ <2>


»ç¾÷ Ã¥ÀÓÀÚ ÀÓÀ翵 ½ÇÀå
Âü¿© ¿¬±¸¿ø ±èÁøÀ̠åÀÓ¿¬±¸¿ø, Á¤½Â¿¬ ¼±ÀÓ¿¬±¸¿ø, 
                 Á¤µ¿¿í ºÎ¼±ÀÓ¿¬±¸¿ø, ÃÖÀ±Á¤ ÁÖÀÓ¿¬±¸¿ø

ÆíÁý ÀÓÀ翵 ½ÇÀå / ÀÌÁÖÇÏ ÁÖÀÓ¿¬±¸¿ø

´ëÇѾà»çȸ¿Í ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò´Â 2020³â ¾ÈÀü»óºñÀǾàǰ ÆÇ¸ÅÀÚ ±³À° °³¼±¹æ¾È ¿¬±¸¸¦ ÁøÇàÇß´Ù. º» ¿¬±¸´Â ÀǾàǰÀÇ ¾à±¹ ¿Ü ÆÇ¸Å·Î ÀÎÇØ ¹ß»ýÇÒ ¼ö Àִ À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ¿î¿µ ÁßÀΠ¾ÈÀü»óºñÀǾàǰ ÆÇ¸ÅÀÚ ±³À°ÀÇ È¿À²¼º Á¦°í¸¦ ¸ñÀûÀ¸·Î ¼öÇàµÆ´Ù.

ÀÌ·¯ÇÑ ¸Æ¶ô¿¡¼­ º» ¿¬±¸´Â ¾ÈÀü»óºñÀǾàǰ ÆÇ¸ÅÀÚ ±³À°È¯°æÀ» Á¶»çÇϱâ À§ÇØ Çö ¾ÈÀü»óºñÀǾàǰ ¾à±¹¿Ü ÆÇ¸ÅÁ¦µµÀÇ ¿î¿µ ½ÇÅ¿͠Ÿ±¹ÀÇ ¾à±¹¿Ü ÆÇ¸ÅÁ¦µµ¸¦ Á¶»çÇß´Ù. Á¶»ç³»¿ë¿¡´Â ¾ÈÀü»óºñÀǾàǰÀÇ À¯Åë½ÇÀû(°ø±Þ¾× ±âÁØ)°ú ¾ÈÀü»óºñÀǾàǰ¿¡ ´ëÇÑ ¼ÒºñÀÚµéÀÇ ±¸¸Å °æÇè°ú ÀνÄÁ¶»ç°¡ Æ÷ÇԵƴÙ.

º» ±Û¿¡¼­´Â ¿¬±¸°úÁ¤¿¡¼­ ¾òÀº ¾ÈÀü»óºñÀǾàǰÀÇ °ø±Þ½ÇÀû°ú ¼ÒºñÀÚµéÀÇ ±¸¸Å °æÇè ¹× ÀνÄÁ¶»ç °á°ú¸¦ Åä´ë·Î ¾ÈÀü»óºñÀǾàǰ ¾à±¹¿Ü ÆÇ¸ÅÁ¦µµÀÇ ¿î¿µ ÇöȲÀ» ÆÄ¾ÇÇØº¸±â·Î ÇÑ´Ù.


<Áö³­È£¿¡ À̾>
¥±. ¾ÈÀü»óºñÀǾàǰ °ø±Þ½ÇÀû
2. ÀϹÝÀǾàǰ °ø±Þ¾× ³» ¾ÈÀü»óºñÀǾàǰ °ø±Þ¾× ºñÁß
¾Õ¼­ »ìÆìº» ¾ÈÀü»óºñÀǾàǰ °ø±Þ¾× Àý´ë±Ô¸ðÀÇ ¼ºÀå Ãß¼¼ À̿ܿ¡, ¾ÈÀü»óºñÀǾàǰÀÌ °ü·ÃµÈ Àüü ÀϹÝÀǾàǰ °ø±Þ¿¡¼­ ¾î´À Á¤µµÀÇ ºñÁßÀ» Â÷ÁöÇϰí ÀÖ°í ±× ºñÁßÀÇ Ãß¼¼°¡ È®´ëµÇ°í ÀÖ´ÂÁö¸¦ È®ÀÎÇØº¸°íÀÚ Ãß°¡ÀûÀΠºÐ¼®À» ÁøÇàÇß´Ù.

°¡Àå Á¤È®ÇÑ ºñ±³ ¹æ¹ýÀº ¾ÈÀü»óºñÀǾàǰ°ú µ¿ÀÏÇѠǰ¸ñÀǠŸ À¯Åë°æ·Î °ø±Þ·®À» ÆÄ¾ÇÇØ ¾ÈÀü»óºñÀǾàǰÀÌ Àüü À¯Åë¿¡¼­ Â÷ÁöÇϴ ºñÁßÀ» °è»êÇϴ °ÍÀÌÁö¸¸, ÀϺΠǰ¸ñÀº ÆÇ¸Å¿ë ÀϹÝÀǾàǰÀ¸·Î ¾à±¹ µî¿¡ °ø±ÞµÇÁö ¾Ê°í Àִ °ü°è·Î ´Ü¼ø ºñ±³°¡ ¾î·Æ´Ù. 

µû¶ó¼­ Ç°¸ñº° ºñ±³¸¦ ÁøÇàÇÏÁö ¾Ê°í, ¾ÈÀü»óºñÀǾàǰÀ¸·Î ÁöÁ¤µÈ 13°³ Ç°¸ñ¿¡ ´ëÀÀÇϴ ATCÄڵ報âÁØ ¿¬°£ °ø±Þ¾×¿¡¼­ ¾ÈÀü»óºñÀǾàǰ °ø±Þ¾×ÀÌ Â÷ÁöÇϴ ºñÁßÀ»°è»êÇϴ ¹æ½ÄÀ» »ç¿ëÇß´Ù.

¾ÈÀü»óºñÀǾàǰÀǠǰ¸ñ ¼ö°¡ Àû°í °¢ ATC Äڵ堳»¿¡¼­µµ ±ØÈ÷ ÀϺΠǰ¸ñ¸¸ÀÌ ¾ÈÀü»óºñÀǾàǰ¿¡ Æ÷ÇԵDZ⠶§¹®¿¡ ´Ü¼øÈ÷ ÀÌ ¼öÄ¡¸¸À¸·Î Á¤È®ÇÑ °ø±Þ »óȲÀ» ÆÄ¾ÇÇÒ ¼ö´Â ¾øÁö¸¸, ´ë·«ÀÇ Ãß¼¼´Â È®ÀÎÇÒ ¼ö ÀÖ´Ù.

¾ÈÀü»óºñÀǾàǰÀÌ Æ÷ÇԵȠATCÄڵ带 ±âÁØÀ¸·Î ÀϹÝÀǾàǰ Àüü °ø±Þ¾× Áß ¾ÈÀü»óºñÀǾàǰ °ø±Þ¾×ÀÌ Â÷ÁöÇϴ ºñÁßÀº 2015³â¿¡ 1.74%¿´À¸³ª Áö¼ÓÀûÀ¸·Î Áõ°¡ÇØ 2019³â¿¡´Â 3.34%·Î 2015³â ´ëºñ 92%ÀÇ Áõ°¡À²À» ³ªÅ¸³Â´Ù<±×¸²1>.


¥². ¼ÒºñÀÚÀÇ ¾ÈÀü»óºñÀǾàǰ ±¸¸Å °æÇè°ú ÀνÄÁ¶»ç
¾ÈÀü»óºñÀǾàǰ ±¸¸Å ¹× ÀνĿ¡ ´ëÇÑ ¼ÒºñÀÚ Á¶»ç´Â 2021³â 1¿ù 14ÀϺÎÅÍ 1¿ù 27ÀϱîÁö ÁøÇàµÇ¾úÀ¸¸ç, Àü¹® Á¶»ç±â°ü ÄÚ¸®¾Æ¸®¼­Ä¡ÀÎÅͳ»¼Å³Î¿¡ ÀÇ·ÚÇØ À¥ ¼³¹®À» ÅëÇØ ÁøÇàÇß´Ù. 

Á¶»ç ´ë»óÀڴ Àü±¹¿¡ °ÅÁÖÇϴ ¸¸ 14¼¼ ÀÌ»ó¡­69¼¼ ÀÌÇÏ ³²³à ÀϹݠ¼ÒºñÀÚ 1000¸íÀ̸砼º, ¿¬·É, 16°³ ½Ã?µµ Áö¿ª¿¡ µû¸¥ Àα¸ºñ·ÊÇÒ´ç¹æ¹ýÀ¸·Î Ç¥º» ÃßÃâÇß´Ù.

¾ÈÀü»óºñÀǾàǰ ±¸¸Å °æÇè¿¡ °üÇÑ Áú¹®ÀÇ ÀÀ´äÀ» <Ç¥3>°ú <Ç¥4>¿¡ ³ªÅ¸³»¾ú´Ù.

ÃÖ±Ù 1³â°£ ÆíÀÇÁ¡¿¡¼­ ¾ÈÀü»óºñÀǾàǰÀ» ±¸ÀÔÇÑ °æÇèÀ» ¹¯´Â Áú¹®¿¡ ±¸ÀÔ °æÇèÀÌ ÀÖ´Ù°í ´ë´äÇÑ ÀÀ´äÀÚ°¡ Àüü ÀÀ´äÀÚÀÇ 61.6%¿´À¸¸ç, ±¸ÀÔÇÑ °æÇèÀÌ ¾ø´Ù°í ´ë´äÇÑ ÀÀ´äÀڴ Àüü ÀÀ´äÀÚÀÇ 38.4%À̾ú´Ù.



¼ºº°¿¡ µû¸¥ ¾ÈÀü»óºñÀǾàǰ ±¸ÀÔ °æÇèÀº Å« Â÷À̸¦ º¸ÀÌÁö ¾Ê¾ÒÀ¸³ª, ¿¬·É´ëº° ¾ÈÀü»óºñÀǾàǰÀÇ ±¸ÀÔ °æÇèÀÇ °á°ú´Â 30´ë Áß¿¡¼­´Â 71.0%, 20´ë Áß¿¡¼­´Â 70.9%·Î, 40´ë Áß¿¡¼­´Â 68.6%·Î ´Ù¸¥ ¿¬·É´ë(10´ë Áß¿¡¼­´Â 39.7%, 60´ë Áß¿¡¼­´Â 49.4%)¿¡ ºñÇØ ³ô¾Ò´Ù.

À̴ ½º½º·Î ÀǾàǰÀ» ±¸ÀÔÇÏÁö ¾ÊÀ» °ÍÀ¸·Î º¸À̴ 10´ëÀÇ °æ¿ì¸¦ Á¦¿ÜÇϸé, 60´ë ÀÌ»ó °í¿¬·ÉÃþ¿¡ ºñÇØ 20´ë¿¡¼­ 40´ë¿¡ ÇØ´çÇϴ ÀþÀº ¿¬·ÉÃþÀÇ ¾ÈÀü»óºñÀǾàǰ ±¸ÀÔ °æÇèÀÇ ºñÀ²ÀÌ »ó´ëÀûÀ¸·Î ³ô´Ù´Â °ÍÀ» ¾Ë ¼ö ÀÖ´Ù.

Áö³­ 1³â°£ ±¸ÀԠȽ¼ö´Â 1~2ȸ°¡ Àüü ÀÀ´äÀÚÀÇ 62.5%¸¦ Â÷ÁöÇß°í, ´ÙÀ½Àº 3~5ȸ°¡ 30.4%¸¦ Â÷ÁöÇØ, Àüü ÀÀ´äÀÚÀÇ 90% ÀÌ»óÀÇ »ç¶÷µéÀÌ 1~5ȸ Á¤µµ ±¸ÀÔÇßÀ½À» ¾Ë ¼ö ÀÖ´Ù. <´ÙÀ½È£¿¡ °è¼Ó>


[±â»çÃâó] https://www.kpanews.co.kr/academy/show.asp?page=1&search_cate=8&idx=659

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
129 [´ëÇѾà»çÀú³Î]°ø°ø½É¾ß¾à±¹, »ç¾÷ È®´ë À§ÇØ ¿î¿µ¡¤ÆíÀÇ °³¼± ÇÊ¿ä ÀÌÁÖÇÏ 2021-09-23 900
128 [´ëÇѾà»çÀú³Î]½É¾ß½Ã°£ ¾à±¹ ÀÌ¿ë '¸¸Á·ÇÑ´Ù' 93.5% ÀÌÁÖÇÏ 2021-09-23 779
127 [´ëÇѾà»çÀú³Î]¿µ±¹, OHH ¼­ºñ½º ÀϹݾࡤÀü¹®¾à ³ª´² Á¦°ø ÀÌÁÖÇÏ 2021-09-23 758
126 [´ëÇѾà»çÀú³Î]È£ÁÖ ¹ãÀ» ¹àÈ÷´Â 'Supercare' ¾à±¹ ÀÌÁÖÇÏ 2021-09-23 764
125 [ÀǾàǰÁ¤Ã¥¸®Æ÷Æ®]ÀÀ´äÀÚ 94.3% µµÀÔ Âù¼º¡¦Àü¹®Àû »ó´ã Àý½Ç ÀÌÁÖÇÏ 2021-09-23 250
124 [´ëÇѾà»çÀú³Î] ¾à ±¸ÀÔ ½Ã ¾à»ç¿Í »ó´ãÀÌ Áß¿ä 85% ÀÌÁö¿¬ 2021-08-10 520
123 [´ëÇѾà»çÀú³Î] ÀǾàǰ ¾ÈÀü»ç¿ë ±³À° 'µµ¿òµÆ´Ù' 98% ÀÌÁö¿¬ 2021-08-02 459
122 [´ëÇѾà»çÀú³Î] ¾ÆÆí ÇÔÀ¯ 'Á¤ÅëÆí' ÅëÁõ ¸¸º´ÅëÄ¡¾àó·³ »ç¿ë ÀÌÁö¿¬ 2021-08-02 506
121 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠó¹æÀǾàǰ È¿°ú ½Å·Ú ´õ ³ô¾Æ ÀÌÁö¿¬ 2021-07-21 448
120 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠÀǾàǰ Àνİú »ç¿ë ÇöȲÀº? ÀÌÁö¿¬ 2021-07-14 390
119 [´ëÇѾà»çÀú³Î] "ºÎÀÛ¿ë °æÇè 98% Áõ»ó ½Å°í¾ÈÇØ" ºÒ°¨Áõ ½É°¢ ÀÌÁö¿¬ 2021-07-07 464
118 [´ëÇѾà»çÀú³Î] ¾ÈÀü»óºñÀǾàǰ ±¸ÀÔ ¿äÀÏ ÁÖ¸» '50.3%' Â÷Áö ÀÌÁö¿¬ 2021-06-29 452
117 [´ëÇѾà»çÀú³Î] ±¹¹Î 90% 1³â°£ ÆíÀÇÁ¡ »óºñ¾à ÃÖ´ë 5ȸ ±¸ÀÔ ÀÌÁö¿¬ 2021-06-22 486
116 [´ëÇѾà»çÀú³Î] ÆíÀÇÁ¡ ºøÀå Ç®¸®ÀÚ ½ñ¾ÆÁø °¨±â¾à¡¤ÁøÅëÁ¦ ÀÌÁö¿¬ 2021-06-16 433
115 [´ëÇѾà»çÀú³Î] Áö¿ª¾à±¹ '»ý¸íÁöÅ´ÀÌ' ¿ªÇÒ ¼öÇà °ü½É ³ôÇû´Ù ÀÌÁö¿¬ 2021-06-09 441

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»